Other analysts also recently issued research reports about the company. Commerzbank set a €77.00 ($91.67) target price on Gerresheimer and gave the stock a buy rating in a research note on Thursday, September 28th. JPMorgan Chase & Co. set a €99.40 ($118.33) price target on Gerresheimer and gave the stock a buy rating in a report on Wednesday, October 11th. Berenberg Bank set a €75.00 ($89.29) price target on Gerresheimer and gave the stock a buy rating in a report on Wednesday, October 11th. Credit Suisse Group set a €80.00 ($95.24) price target on Gerresheimer and gave the stock a buy rating in a report on Tuesday, October 10th. Finally, set a €65.00 ($77.38) price target on Gerresheimer and gave the stock a neutral rating in a report on Tuesday, October 17th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the stock. Gerresheimer has a consensus rating of Hold and a consensus price target of €71.02 ($84.55).
Shares of Gerresheimer (GXI) traded up €0.30 ($0.36) on Thursday, hitting €71.45 ($85.06). The stock had a trading volume of 104,674 shares, compared to its average volume of 110,116. Gerresheimer has a 1 year low of €59.97 ($71.39) and a 1 year high of €78.25 ($93.15). The stock has a market capitalization of $2,240.00 and a P/E ratio of 50.67.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.